Novel percutaneous catheter thrombectomy in acute massive pulmonary embolism: rotational bidirectional thrombectomy (ROBOT)

Catheter Cardiovasc Interv. 2006 Jul;68(1):112-7. doi: 10.1002/ccd.20747.

Abstract

Background: Although thrombolysis is a standard therapy in cases of pulmonary embolism (PE), fatal outcome is often observed. We designed and investigated the efficacy of a novel percutaneous catheter therapy, rotational bidirectional thrombectomy (ROBOT), for PE.

Methods and results: Eighteen patients with acute massive PE (Miller score > or = 20) were included in this study. We separated them into two groups [group A (n = 10), thrombolysis; group B (n = 8): thrombolysis and ROBOT or ROBOT alone]. There was no difference in the hemodynamic indices between the groups at diagnosis. ROBOT was designed to fragment emboli by rotating a regular pigtail catheter. Three deaths occurred in group A because of hemodynamic impairment, but there was no death in group B. One day after treatment, systolic pulmonary artery pressure had decreased from 53 +/- 8 to 30 +/- 8 mm Hg (P < 0.05) in group B and from 54 +/- 5 to 42 +/- 19 mm Hg (NS) in group A. The hospitalization period in group B was shorter than that in group A (17 +/- 6 vs. 27 +/- 10 days, P < 0.05).

Conclusion: ROBOT therapy results in a significant, rapid improvement in the hemodynamic situation and in a better outcome than conventional therapy in patients with acute massive pulmonary embolism.

MeSH terms

  • Acute Disease
  • Aged
  • Anticoagulants / therapeutic use
  • Blood Pressure
  • Catheterization* / instrumentation
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Pulmonary Artery / diagnostic imaging
  • Pulmonary Artery / physiopathology
  • Pulmonary Embolism / drug therapy
  • Pulmonary Embolism / surgery
  • Pulmonary Embolism / therapy*
  • Radiography, Interventional
  • Research Design
  • Retrospective Studies
  • Severity of Illness Index
  • Thrombectomy / instrumentation
  • Thrombectomy / methods*
  • Time Factors
  • Treatment Outcome
  • Vena Cava Filters

Substances

  • Anticoagulants
  • Fibrinolytic Agents